The ACE2/Ang (1–7)/MasR pathway has many characteristics which make it an attractive potential target to induce neuroprotection in the context of stroke [21] and, importantly, all of the components of the ACE2/Ang (1–7)/MasR axis are already expressed by cells within the CNS [21,22]. The gene discussed is MAS1L; the disease is stroke disorder.